{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:15Z","timestamp":1762876035550},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40618-018-0972-3","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T07:15:36Z","timestamp":1541661336000},"page":"693-698","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case\u2013control study in an Italian cohort"],"prefix":"10.1007","volume":"42","author":[{"given":"T.","family":"Pilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dalmiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Secchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fralassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cevenini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Cairano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Maino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Forleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"972_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","volume":"8","author":"A Bellis De","year":"2005","unstructured":"De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8:25\u201330","journal-title":"Pituitary"},{"key":"972_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12016-009-8185-3","volume":"40","author":"LJ Jara","year":"2011","unstructured":"Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C (2011) Prolactin and autoimmunity. Clin Rev Allergy Immunol 40:50\u201359","journal-title":"Clin Rev Allergy Immunol"},{"key":"972_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0165-5728(00)00302-7","volume":"109","author":"L Matera","year":"2000","unstructured":"Matera L, Mori M, Geuna M, Buttiglieri S, Palestro G (2000) Prolactin in autoimmunity and antitumor defence. J Neuroimmunol 109:47\u201355","journal-title":"J Neuroimmunol"},{"key":"972_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12016-011-8256-0","volume":"42","author":"H Orbach","year":"2012","unstructured":"Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Blank M, Shoenfeld Y (2012) Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol 42:189\u2013198","journal-title":"Clin Rev Allergy Immunol"},{"key":"972_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.autrev.2011.11.009","volume":"11","author":"S Shelly","year":"2012","unstructured":"Shelly S, Boaz M, Orbach H (2012) Prolactin and autoimmunity. Autoimmun Rev 11:465\u2013470","journal-title":"Autoimmun Rev"},{"key":"972_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1568-9972(02)00081-2","volume":"1","author":"O Vera-Lastra","year":"2002","unstructured":"Vera-Lastra O, Jara LJ, Espinoza LR (2002) Prolactin and autoimmunity. Autoimmun Rev 1:360\u2013364","journal-title":"Autoimmun Rev"},{"key":"972_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1177\/0961203314531083","volume":"23","author":"MF Ugarte-Gil","year":"2014","unstructured":"Ugarte-Gil MF, Gamboa-C\u00e1rdenas RV, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, Alfaro-Lozano JL, Rodriguez-Bellido Z, Alarc\u00f3n GS, Pastor-Asurza CA (2014) High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus 23:969\u2013974","journal-title":"Lupus"},{"key":"972_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2172-13-11","volume":"13","author":"Y Ledesma-Soto","year":"2012","unstructured":"Ledesma-Soto Y, Blanco-Favela F, Fuentes-Panan\u00e1 EM, Tesoro-Cruz E, Hern\u00e1ndez-Gonz\u00e1lez R, Arriaga-Pizano L, Legorreta-Haquet MV, Montoya-Diaz E, Ch\u00e1vez-S\u00e1nchez L, Castro-Mussot ME, Ch\u00e1vez-Rueda AK (2012) Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment. BMC Immunol 13:11","journal-title":"BMC Immunol"},{"key":"972_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2265.1984.tb03231.x","volume":"21","author":"EG Lever","year":"1984","unstructured":"Lever EG, McKerron CG (1984) Auto-immune Addison\u2019s disease associated with hyperprolactinemia. Clin Endocrinol 21:451\u2013457","journal-title":"Clin Endocrinol"},{"key":"972_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/acta.0.1040035","volume":"104","author":"C Ferrari","year":"1983","unstructured":"Ferrari C, Boghen M, Paracchi A, Rampini P, Raiteri F, Benco R, Romussi M, Codecasa F, Mucci M, Bianco M (1983) Thyroid autoimmunity in hyperprolactinemic disorders. Acta Endocrinol 104:35\u201341","journal-title":"Acta Endocrinol"},{"key":"972_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s100670200076","volume":"21","author":"A Zoli","year":"2002","unstructured":"Zoli A, Lizzio MM, Ferlisi EM, Massafra V, Mirone L, Barini A, Scuderi F, Bartolozzi F, Magar\u00f3 M (2002) ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol 21:289\u2013293","journal-title":"Clin Rheumatol"},{"key":"972_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/BF02229718","volume":"15","author":"EJ Kucharz","year":"1996","unstructured":"Kucharz EJ, Jarczyk R, Jonderko G, Rubisz-Brezezi\u0144ska J, Brzezi\u0144ska-Wcislo L (1996) High serum level of prolactin in patients with systemic sclerosis. Clin Rheumatol 15:314","journal-title":"Clin Rheumatol"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1297-319X(03)00151-9","volume":"71","author":"YM Miedany El","year":"2004","unstructured":"El Miedany YM, Ahmed I, Moustafa H, El Baddini M (2004) Hyperprolactinemia in Sjogren\u2019s syndrome: a patient subset or a disease manifestation? Joint Bone Spine 71:203\u2013208","journal-title":"Joint Bone Spine"},{"key":"972_CR14","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1084\/jem.184.5.2043","volume":"184","author":"GS Duncan","year":"1996","unstructured":"Duncan GS, Mittr\u00fccker HW, K\u00e4gi D, Matsuyama T, Mak TW (1996) The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 184:2043\u20132048","journal-title":"J Exp Med"},{"key":"972_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12016-009-8182-6","volume":"40","author":"S Saha","year":"2011","unstructured":"Saha S, Tieng A, Pepeljugoski KP, Zandamn-Goddard G, Peeva E (2011) Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models. Clin Rev Allergy Immunol 40:8\u201315","journal-title":"Clin Rev Allergy Immunol"},{"key":"972_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1749-6632.1999.tb07629.x","volume":"876","author":"IC Chikanza","year":"1999","unstructured":"Chikanza IC (1999) Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 876:119\u2013130","journal-title":"Ann N Y Acad Sci"},{"key":"972_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11102-015-0699-5","volume":"19","author":"V Larouche","year":"2016","unstructured":"Larouche V, Correa JA, Cassidy P, Beauregard C, Garfield N, Rivera J (2016) Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas. Pituitary 19:202\u2013209","journal-title":"Pituitary"},{"key":"972_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12020-017-1372-8","volume":"57","author":"A Elenkova","year":"2017","unstructured":"Elenkova A, Atanasova I, \u041airilov G, Natchev E, Ivanova R, \u041aovatcheva R, Vandeva S, Tcharaktchiev D, Zacharieva S (2017) Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study. Endocrine 57:486\u2013493","journal-title":"Endocrine"},{"key":"972_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1507\/endocrj1954.38.517","volume":"38","author":"M Ishibashi","year":"1991","unstructured":"Ishibashi M, Kuzuya N, Sawada S, Kitamura K, Kamoi K, Yamaji T (1991) Anti-thyroid antibodies in patients with hyperprolactinemia. Endocrinol Jpn 38:517\u2013522","journal-title":"Endocrinol Jpn"},{"key":"972_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/cen.12217","volume":"79","author":"M Sayki Arslan","year":"2013","unstructured":"Sayki Arslan M, Sahin M, Topaloglu O, Tutal E, Karakose M, Gungunes A, Cakal E, Ozbek M, Delibasi T (2013) Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin Endocrinol (Oxf) 79:882\u2013886","journal-title":"Clin Endocrinol (Oxf)"},{"key":"972_CR21","unstructured":"http:\/\/www.iccidd.org\/"},{"key":"972_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1210\/jc.2012-2960","volume":"98","author":"A Aghini Lombardi","year":"2013","unstructured":"Aghini Lombardi A, Fiore E, Tonacchera M, Antonangeli L, Rago T, Frigeri M, Provenzale AM, Montanelli L, Grasso L, Pinchera A, Vitti P (2013) The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15\u00a0years later. J Clin Endocrinol Metab 98:1031\u20131039","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1590\/0004-2730000002846","volume":"58","author":"ED Onal","year":"2014","unstructured":"Onal ED, Saglam F, Sacikara M, Ersoy R, Cakir B (2014) Thyroid autoimmunity in patients with hyperprolactinemia: an observational study. Arq Bras Endocrinol Metabol 58:48\u201352","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"972_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ando.2015.10.008","volume":"77","author":"A Elenkova","year":"2016","unstructured":"Elenkova A, Petrossians P, Zacharieva S, Beckers A (2016) High prevalence of autoimmune thyroid diseases in patients with prolactinomas: a cross-sectional retrospective study in a single tertiary referral centre. Ann. Endocrinol (Paris) 77:37\u201342","journal-title":"Ann. Endocrinol (Paris)"},{"key":"972_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S2213-8587(14)70225-6","volume":"3","author":"MB Zimmermann","year":"2015","unstructured":"Zimmermann MB, Boelaert K (2015) Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 3:286\u2013295","journal-title":"Lancet Diabetes Endocrinol"},{"key":"972_CR26","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1056\/NEJMoa054022","volume":"354","author":"W Teng","year":"2006","unstructured":"Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354:2783\u20132793","journal-title":"N Engl J Med"},{"key":"972_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/eje.1.02068","volume":"154","author":"A Carl\u00e8","year":"2006","unstructured":"Carl\u00e8 A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jorgensen T (2006) Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol 154:21\u201328","journal-title":"Eur J Endocrinol"},{"key":"972_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MPJ Vanderpump","year":"2011","unstructured":"Vanderpump MPJ (2011) The epidemiology of thyroid disease. Br Med Bull 99:39\u201351","journal-title":"Br Med Bull"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0972-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:18:47Z","timestamp":1573172327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0972-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0972-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}